Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, PD and Safety of V1512 vs Sinemet in Parkinson's Disease
NCT00491998Phase 2Completed
- Sponsor
- Vernalis
- Start
- Nov 2006
- Primary completion
- Nov 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of melevodopa in Parkinson's disease (PD), sponsored by Vernalis. Started Nov 2006; status: completed.
02
Drugs
melevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00491998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491998.